Medicare Enrolled

Dr. Jose Garcia, MD

Rheumatology · Pembroke Pines, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12151 TAFT ST, Pembroke Pines, FL 33026
9547041050
In practice since 2006 (19 years)
NPI: 1407896558 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garcia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garcia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garcia

Dr. Jose Garcia is a rheumatology specialist in Pembroke Pines, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Garcia performed 3,986 Medicare services across 352 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garcia received a total of $19,070 from 53 pharmaceutical and/or device companies across 940 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garcia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 3,986 Medicare services $19,070 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 59946 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
3,986
Medicare services
Bottom 46% in FL for rheumatology
352
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~210 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,400 $18 $29
Physical therapy exercise, per 15 min 323 $18 $51
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 220 $59 $119
Office visit, established patient (30-39 min) 211 $95 $169
Self-care/home management training, per 15 min 178 $26 $54
Manual therapy (hands-on treatment), per 15 min 174 $17 $46
Neuromuscular re-education therapy, per 15 min 165 $20 $52
Office visit, established patient (20-29 min) 88 $67 $114
Administration of chemotherapy into vein, 1 hour or less 70 $106 $213
Blood draw (venipuncture) 52 $7 $8
Joint injection, major joint 50 $52 $138
New patient office visit (45-59 min) 25 $132 $261
Office visit, established patient (10-19 min) 18 $40 $69
Evaluation for occupational therapy, typically 30 minutes 12 $81 $136
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,070
Total received (2018-2024)
Avg $2,724/year across 7 years
Top 23% in FL for rheumatology
53
Companies
940
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,959 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$111 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,002
2023
$2,299
2022
$2,373
2021
$2,431
2020
$2,598
2019
$3,302
2018
$3,066

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,088
UCB, Inc.
$1,551
GlaxoSmithKline, LLC.
$1,361
Mallinckrodt Hospital Products Inc.
$1,284
Janssen Biotech, Inc.
$1,020
E.R. Squibb & Sons, L.L.C.
$999
ABBVIE INC.
$973
Horizon Therapeutics plc
$962
Lilly USA, LLC
$826
AbbVie, Inc.
$771
Radius Health, Inc.
$770
AstraZeneca Pharmaceuticals LP
$600
Aurinia Pharma U.S., Inc.
$572
Novartis Pharmaceuticals Corporation
$494
Genentech USA, Inc.
$458
ANI Pharmaceuticals, Inc.
$453
AbbVie Inc.
$410
PFIZER INC.
$384
GENZYME CORPORATION
$289
SANOFI-AVENTIS U.S. LLC
$285
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
Sobi, Inc
$166
Janssen Scientific Affairs, LLC
$160
Celgene Corporation
$154
Mallinckrodt LLC
$152
Fresenius Kabi USA, LLC
$132
Alvogen Inc
$123
SCILEX PHARMACEUTICALS INC.
$119
Pacira Therapeutics, Inc.
$116
Kiniksa Pharmaceuticals International, plc
$114
Genentech, Inc.
$100
Actelion Pharmaceuticals US, Inc.
$89
Horizon Pharma plc
$80
MEDAC PHARMA, INC.
$63
IBSA Pharma Inc.
$62
Organon LLC
$58
Teva Pharmaceuticals USA, Inc.
$57
MEDEXUS PHARMA, INC.
$56
Kyowa Kirin, Inc.
$53
Flexion Therapeutics, Inc.
$49
Mallinckrodt Enterprises LLC
$48
Alexion Pharmaceuticals, Inc.
$44
Ultragenyx Pharmaceutical Inc.
$38
Octapharma USA, Inc.
$32
West-Ward Pharmaceuticals
$30
Fidia Pharma USA Inc.
$24
Hikma Pharmaceuticals USA
$22
Celltrion USA Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Cumberland Pharmaceuticals, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Gilead Sciences, Inc.
$16
Organon Llc
$10
Top 3 companies account for 26.2% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · Cimzia · Crysvita · DUEXIS · EVENITY · Enbrel · FASENRA · FORTEO · HADLIMA · HUMIRA · HYMOVIS · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Licart · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · PENNSAID · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tirosint · Truxima · Tymlos · Uloric · VIMOVO · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $478 per 100 Medicare services performed
Looking for a rheumatology specialist in Pembroke Pines?
Compare rheumatologists in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
101
Per 100K population
5.2
County median income
$74,534
Nearest hospital
SOUTH FLORIDA STATE HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garcia is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garcia experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Garcia performed 2,400 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garcia receive payments from pharmaceutical companies?
Yes. Dr. Garcia received a total of $19,070 from 53 companies across 940 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garcia's costs compare to other rheumatologists in Pembroke Pines?
Dr. Garcia's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garcia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →